The dangers of iron overload in pyruvate kinase deficiency.
Marshall
Scott R
SR
Saunders
Peter W G
PW
Hamilton
Peter J
PJ
Taylor
Penelope R A
PR
D000368:Aged; D002614:Chelating Agents / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D019190:Iron Overload / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D008099:Liver / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D010179:Pancreas / Q000473:pathology*; D010349:Patient Compliance; D011770:Pyruvate Kinase / Q000172:deficiency*; D015323:Pyruvate Metabolism, Inborn Errors / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D013156:Splenectomy
D002614:Chelating Agents; D011770:Pyruvate Kinase; D003676:Deferoxamine